Genomic polymorphisms in 3β-hydroxysterol Δ24-reductase promoter sequences

Microbiology and Immunology

Volumn 57, Issue 3, 2013, Pages 179-184

  Salem, Nagla Elwy ^a,b   Saito, Makoto ^a   Kasama, Yuri ^a   Ozawa, Makoto ^c   Kawabata, Toshiko ^c   Harada, Shinji ^a   Suda, Hiroko ^a   Asonuma, Katsuhiro ^a   El Gohary, Ahmed ^b   Tsukiyama Kohara, Kyoko ^a,c  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Suez Canal University Faculty of Medicine   (Egypt)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

3 hydroxysterol 24 reductase; Hepatitis C virus; Promoter

Indexed keywords

INTERFERON; NUCLEOTIDE;

3 BETA HYDROXYSTEROL DELTA 24 REDUCTASE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TYPE; CONTROLLED STUDY; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; HEPATITIS C; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REPLICON; SEQUENCE ANALYSIS;

AGED; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MICE; MIDDLE AGED; NERVE TISSUE PROTEINS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 84875278834     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/1348-0421.12025     Document Type: Article

References (19)

1. Wong C.M., Ng I.O. (2008) Molecular pathogenesis of hepatocellular carcinoma. Liver Int 28: 160-74.
2. Center M.M., Jemal A. (2011) International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev 20: 2362-8.
3. Perz J.F., Armstrong G.L., Farrington L.A., Hutin Y.J., Bell B.P. (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45: 529-38.
4. Altekruse S.F., McGlynn K.A., Reichman M.E. (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27: 1485-91.
5. Farazi P.A., DePinho R.A. (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6: 674-87.
6. Greeve I., Hermans-Borgmeyer I., Brellinger C., Kasper D., Gomez-Isla T., Behl C., Levkau B., Nitsch R.M. (2000) The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J Neurosci 20: 7345-52.
7. Wu C., Miloslavskaya I., Demontis S., Maestro R., Galaktionov K. (2004) Regulation of cellular response to oncogenic and oxidative stress by Seladin-1. Nature 432: 640-5.
8. Nishimura T., Kohara M., Izumi K., Kasama Y., Hirata Y., Huang Y., Shuda M., Mukaidani C., Takano T., Tokunaga Y., Nuriya H., Satoh M., Saito M., Kai C., Tsukiyama-Kohara K. (2009) Hepatitis C virus impairs p53 via persistent overexpression of 3beta-hydroxysterol delta24-reductase. J Biol Chem 284: 36442-52.
9. Takano T., Tsukiyama-Kohara K., Hayashi M., Hirata Y., Satoh M., Tokunaga Y., Tateno C., Hayashi Y., Hishima T., Funata N., Sudoh M., Kohara M. (2011) Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes. J Hepatol 55: 512-21.
10. Saito M., Kohara M., Tsukiyama-Kohara K. (2012) Hepatitis C virus promotes expression of the 3beta-hydroxysterol delta24-reductase through Sp1. J Med Virol 84: 733-46.
11. Watanabe T., Sudoh M., Miyagishi M., Akashi H., Arai M., Inoue K., Taira K., Yoshiba M., Kohara M. (2006) Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype. Gene Ther 13: 883-92.
12. Blight K.J., McKeating J.A., Rice C.M. (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76: 13001-14.
13. Mercer D.F., Schiller D.E., Elliott J.F., Douglas D.N., Hao C., Rinfret A., Addison W.R., Fischer K.P., Churchill T.A., Lakey J.R., Tyrrell D.L., Kneteman N.M. (2001) Hepatitis C virus replication in mice with chimeric human livers. Nat Med 7: 927-33.
14. Inoue K., Umehara T., Ruegg U.T., Yasui F., Watanabe T., Yasuda H., Dumont J.M., Scalfaro P., Yoshiba M., Kohara M. (2007) Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo. Hepatology 45: 921-8.
15. Hecht N.B. (1995) The making of a spermatozoon: a molecular perspective. Dev Genet 16: 95-103.
16. Kim J., Sharma S., Li Y., Cobos E., Palvimo J.J., Williams S.C. (2005) Repression and coactivation of CCAAT/enhancer-binding protein epsilon by sumoylation and protein inhibitor of activated STATx proteins. J Biol Chem 280: 12, 246-54.
17. Shiojima I., Komuro I., Mizuno T., Aikawa R., Akazawa H., Oka T., Yamazaki T., Yazaki Y. (1996) Molecular cloning and characterization of human cardiac homeobox gene CSX1. Circ Res 79: 920-9.
18. Rikitake Y., Moran E. (1992) DNA-binding properties of the E1A-associated 300-kilodalton protein. Mol Cell Biol 12: 2826-36.
19. Aizaki H., Lee K.J., Sung V.M., Ishiko H., Lai M.M. (2004) Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology 324: 450-61.